Free Trial
TSE:OGI

Organigram (OGI) Stock Price, News & Analysis

Organigram logo
C$2.36
-0.10 (-4.07%)
(As of 10/31/2024 ET)

About Organigram Stock (TSE:OGI)

Key Stats

Today's Range
C$2.36
C$2.47
50-Day Range
C$2.29
C$2.74
52-Week Range
C$1.41
C$3.95
Volume
175,278 shs
Average Volume
302,260 shs
Market Capitalization
C$256.23 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
C$3.98
Consensus Rating
Moderate Buy

Company Overview

Organigram Holdings Inc., through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Edison JOLTS, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative-based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as consumer channels. The company was incorporated in 2010 and is headquartered in Toronto, Canada.

Organigram Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
68th Percentile Overall Score

OGI MarketRank™: 

Organigram scored higher than 68% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Organigram has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 3 buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Organigram has only been the subject of 1 research reports in the past 90 days.

  • Read more about Organigram's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Organigram is -0.94, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Organigram is -0.94, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Growth Ratio

    Organigram has a PEG Ratio of 0.42. PEG Ratios below 1 indicate that a company could be undervalued.

  • Price to Book Value per Share Ratio

    Organigram has a P/B Ratio of 0.83. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Organigram's valuation and earnings.
  • Short Interest

    There is no current short interest data available for OGI.
  • Dividend Yield

    Organigram does not currently pay a dividend.

  • Dividend Growth

    Organigram does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for OGI.
  • News Sentiment

    Organigram has a news sentiment score of 0.63. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for Organigram this week, compared to 1 article on an average week.
  • Search Interest

    8 people have searched for OGI on MarketBeat in the last 30 days. This is an increase of 300% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Organigram insiders have sold more of their company's stock than they have bought. Specifically, they have bought C$0.00 in company stock and sold C$93,750.00 in company stock.

  • Percentage Held by Insiders

    31.32% of the stock of Organigram is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 8.37% of the stock of Organigram is held by institutions.

  • Read more about Organigram's insider trading history.
Receive OGI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Organigram and its competitors with MarketBeat's FREE daily newsletter.

OGI Stock News Headlines

Organigram (TSE:OGI) Shares Down 0.8% - Here's What Happened
625,000% Gain
The recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull run is over. But if history has taught us anything, it’s that this is only the beginning.
Organigram: Why I Still Like It
Organigram Holdings Inc. (OGI.TO)
See More Headlines

OGI Stock Analysis - Frequently Asked Questions

Organigram's stock was trading at C$1.72 at the start of the year. Since then, OGI stock has increased by 37.2% and is now trading at C$2.36.
View the best growth stocks for 2024 here
.

Organigram Holdings Inc. (TSE:OGI) released its quarterly earnings data on Tuesday, August, 13th. The company reported $0.03 earnings per share for the quarter, topping analysts' consensus estimates of ($0.07) by $0.10. The business had revenue of $41.06 million for the quarter, compared to analyst estimates of $39.20 million. Organigram had a negative trailing twelve-month return on equity of 54.53% and a negative net margin of 153.80%.

Shares of OGI stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Organigram investors own include Canopy Growth (CGC), Aurora Cannabis (ACB), Innovative Industrial Properties (IIPR), Aurora Cannabis (ACB), Canopy Growth (WEED), Aphria (APHA) and NVIDIA (NVDA).

Company Calendar

Last Earnings
8/13/2024
Today
10/31/2024
Next Earnings (Estimated)
12/17/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
Cannabis
CIK
N/A
Fax
N/A
Employees
987
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
C$3.98
High Stock Price Target
C$5.25
Low Stock Price Target
C$2.70
Potential Upside/Downside
+61.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
4 Analysts

Profitability

Net Income
C$-229,480,000.00
Net Margins
-153.80%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$149.21 million
Cash Flow
C$0.64 per share
Book Value
C$2.85 per share

Miscellaneous

Free Float
N/A
Market Cap
C$267.08 million
Optionable
Not Optionable
Beta
1.13
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

This page (TSE:OGI) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners